【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 8
1.1 List of Tables 15
1.2 List of Figures 18
2 Introduction 20
2.1 Catalyst 20
2.2 Related Reports 20
2.3 Upcoming Related Reports 20
3 Disease Overview 21
3.1 Etiology and Pathophysiology 21
3.1.1 Etiology 21
3.1.2 Pathophysiology 23
3.2 Prognosis 27
3.3 Quality of Life 27
3.4 Symptoms 28
4 Epidemiology 30
4.1 Risk Factors and Comorbidities 30
4.1.1 Age and sex are highly associated with the risk of chronic heart failure 32
4.1.2 History of cardiovascular disease increases the risk of developing chronic heart failure 32
4.1.3 Unhealthy lifestyles increase the risk of chronic heart failure 33
4.1.4 People with diabetes mellitus are twice as likely to develop chronic heart failure 33
4.1.5 Nearly 20% of patients with chronic kidney disease develop chronic heart failure 34
4.1.6 Comorbidities 34
4.1.7 Prognosis for chronic heart failure remains poor 35
4.2 Global Trends 36
4.2.1 United States 36
4.2.2 France 37
4.2.3 Germany 38
4.2.4 Italy 38
4.2.5 Spain 38
4.2.6 United Kingdom 39
4.2.7 Japan 39
4.2.8 China 40
4.3 Forecast Methodology 40
4.3.1 Sources Used 40
4.3.2 Forecast Assumptions and Methods 45
4.3.3 Forecast Assumptions and Methods for New York Heart Association Class Distributions 48
4.3.4 Sources Not Used 49
4.4 Epidemiology Forecast (2012-2022) 49
4.4.1 Prevalent Cases of Chronic Heart Failure 49
4.4.2 Age-Specific Prevalent Cases 52
4.4.3 Sex-Specific Prevalent Cases 54
4.4.4 Age-Standardized Prevalence 59
4.4.5 New York Heart Association Class Distributions 61
4.5 Discussion 62
4.5.1 Limitations of Analysis 64
4.5.2 Strengths of Analysis 64
5 Disease Management 65
5.1 Treatment Overview 66
5.1.1 Pharmacological Treatments 68
5.1.2 Mechanical Devices 74
5.2 US 75
5.2.1 Diagnosis and Referral Patterns 75
5.2.2 Clinical Practice 76
5.3 France 77
5.3.1 Diagnosis and Referral Patterns 77
5.3.2 Clinical Practice 78
5.4 Germany 80
5.4.1 Diagnosis and Referral Patterns 80
5.4.2 Clinical Practice 80
5.5 Italy 82
5.5.1 Diagnosis and Referral Patterns 82
5.5.2 Clinical Practice 82
5.6 Spain 84
5.6.1 Diagnosis and Referral Patterns 84
5.6.2 Clinical Practice 85
5.7 UK 87
5.7.1 Diagnosis and Referral Patterns 87
5.7.2 Clinical Practice 88
5.8 Japan 90
5.8.1 Diagnosis and Referral Patterns 90
5.8.2 Clinical Practice 90
6 Competitive Assessment 92
6.1 Overview 92
6.2 Strategic Competitor Assessment 92
6.3 Drug Profiles 95
6.3.1 Angiotensin-Converting Enzyme (ACE) Inhibitors 95
6.3.2 Diuretics 98
6.3.3 Angiotensin Receptor Blockers 100
6.3.4 Beta Blockers 113
6.3.5 Procoralan (ivabradine) 125
6.3.6 Mineralocorticoid Receptor Antagonists 129
6.3.7 Digoxin 132
7 Opportunity and Unmet Need 135
7.1 Overview 135
7.2 Lack of Therapies for HF-PEF Patients 136
7.3 Lack of Therapies for Patients with Renal Impairment 137
7.4 Diagnosis of Asymptomatic Left Ventricular Dysfunction 137
7.5 Treatment of Patients with Multiple Comorbidities 138
7.6 Increase in Survival of CHF Patients 138
7.7 Unmet Needs Gap Analysis 139
7.8 Opportunity: Treatment of Patients with HF-PEF 140
7.9 Opportunity: Therapies for Patients with Renal Impairment and Multiple Comorbidities 140
7.10 Opportunity: New Drugs that Show Increase in Survival of CHF Patients 140
8 Pipeline Assessment 141
8.1 Overview 141
8.1.1 Clinical Trials by Country 142
8.2 Clinical Trials by Phase and Trial Status 143
8.3 Promising Drugs in Clinical Development 144
8.3.1 LCZ-696 145
8.3.2 Tekturna (aliskiren) 151
8.3.3 Neucardin (rhNRG-1) 155
8.4 Innovative Early-Stage Approaches 159
8.4.1 BAY 94-8862 159
8.4.2 Omecamtiv mecarbil 162
8.5 Promising Non-Pharmacological Approaches 165
8.5.1 MyoCell 166
8.5.2 C-Cure (C3BS-CQR-1) 171
8.5.3 Mydicar (rAAV1-SERCA2a) 174
9 Current and Future Players 179
9.1 Overview 179
9.2 Trends in Corporate Strategy 180
9.3 Company Profiles 181
9.3.1 Novartis 181
10 Market Outlook 185
10.1 Global Markets 185
10.1.1 Forecast 185
10.1.2 Drivers and Barriers – Global Issues 188
10.2 United States 191
10.2.1 Forecast 191
10.2.2 Key Events 195
10.2.3 Drivers and Barriers 195
10.3 France 197
10.3.1 Forecast 197
10.3.2 Key Events 200
10.3.3 Drivers and Barriers 200
10.4 Germany 201
10.4.1 Forecast 201
10.4.2 Key Events 204
10.4.3 Drivers and Barriers 204
10.5 Italy 205
10.5.1 Forecast 205
10.5.2 Key Events 207
10.5.3 Drivers and Barriers 208
10.6 Spain 209
10.6.1 Forecast 209
10.6.2 Key Events 211
10.6.3 Drivers and Barriers 212
10.7 United Kingdom 213
10.7.1 Forecast 213
10.7.2 Key Events 216
10.7.3 Drivers and Barriers 216
10.8 Japan 217
10.8.1 Forecast 217
10.8.2 Key Events 220
10.8.3 Drivers and Barriers 220
11 Appendix 223
11.1 Bibliography 223
11.2 Abbreviations 240
11.3 Methodology 244
11.4 Forecasting Methodology 244
11.4.1 NYHA Class Segmentation of Total Prevalent CHF Population 244
11.4.2 Diagnosed CHF Population 245
11.4.3 Drug-Treated CHF Population 246
11.4.4 Patient Population Breakdown: HF-REF versus HF-PEF 246
11.4.5 Treatment of HF-REF versus HF-PEF 246
11.4.6 Drugs Included in Each Therapeutic Class 247
11.4.7 Launch and Patent Expiry Dates 247
11.4.8 General Pricing Assumptions 248
11.4.9 Drugs Assumptions 249
11.4.10 Generic Erosion 254
11.4.11 Pricing of Pipeline Agents 254
11.5 Physicians and Specialists Included in this Study 255
11.6 Survey of Prescribing Physicians 256
11.7 About the Authors 257
11.7.1 Author 257
11.7.2 Epidemiologist 257
11.7.3 Global Head of Healthcare 258
11.8 About GlobalData 259
【レポート販売概要】
■ タイトル:慢性心不全:世界市場(医薬品市場予測及び分析~2022)■ 英文:PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022
■ 発行日:2013年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403161290
■ 調査対象地域:グローバル
- 販売実績管理(SPM)ソリューションの世界市場:インセンティブ/報酬管理、テリトリー管理、販売計画およびモニタリング、販売分析The increasing business progressions across organizations are significantly transforming the operational patterns for organizations worldwide. This has invariably led to the obligatory need to drive sales so as to derive more revenues for the company through enhanced customer engagement. With the definite realization that boosted sales force form the core valuable asset for organizations that defi …
- 2G/3G/4G無線ネットワークインフラ市場(2014-2020):The 2G, 3G and 4G Wireless Network Infrastructure Market: 2014 -2020 – with an Evaluation of WiFi and WiMAXThe wireless network infrastructure market is currently in a phase of transition as mobile network operators seek to address increasing mobile traffic demands amidst global economic uncertainties. This paradigm shift is bringing new challenges and opportunities to infrastructure vendors. In 2013, global 2G, 3G and 4G wireless infrastructure revenues stood at $52 Billion. SNS Research estimates tha …
- 航空機シート用装飾材料の世界市場予測(~2025年)Increasing aircraft orders across the globe are driving the market growth. The aircraft seat upholstery market size is projected to grow from USD 1.2 billion in 2019 to USD 1.8 billion by 2025, at a CAGR of 7.3% during the forecast period. The market is driven by factors such as increasing aircraft orders across the globe, rising number of premium economy seats, growing demand for customized seats …
- カリウム(Potassium)の市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Potassium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories C …
- 油田向け通信ソリューションの世界市場予測(~2022年)“Increase in integration of departments in the oil and gas industry is driving the oilfield communications market”The oilfield communications market size is estimated to grow from USD 3.05 billion in 2017 to USD 4.46 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 7.9%. Integration of departments in the oil and gas industry and increasing significance of cyber security are some of the …
- 発泡ポリスチレン(EPS)の世界市場予測The expanded polystyrene market size, in terms of value, is estimated to reach USD 17.74 Billion by 2020, signifying a firm CAGR of over 6.03% between 2015 and 2020.The expanded polystyrene market registered a moderate growth in the past few years, which is expected to continue in the coming years. This growth is driven by the growing of building & construction and packaging industries. Currently, …
- ガストリンの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Gastrin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories POC …
- パーキンソン病ワクチンのグローバル市場機会分析(MarketVIEW: Parkinson disease)Parkinson’s disease is a degenerative disorder of the central nervous system where main symptoms are tremor at rest, stiffness, slowing of movement and postural instability. It is estimated that 6.3 million people have Parkinson’s worldwide, affecting all races and cultures. After Alzheimer’s, it is the second most prevalent neurodegenerative disorder, affecting 1% of those over 60, and 4% of thos …
- オープンスタック(OpenStack)サービスの世界市場About OpenStack services OpenStack is an open-source cloud-based computing technology that was initiated as a joint project by Rackspace and NASA in 2010. Currently, it is supported by vendors, including Cisco, Dell, HP, IBM, Intel, Oracle, Red Hat, and Vmware. The Openstack foundation has attracted global attention not only toward contribution to the development and improvisation of the software …
- IoTにおけるビックデータの世界市場:主要動向、機会、予測Billions of devices generate data associated with various enterprise and consumer lifestyle events such as shopping activity, utility usage and other smart grid data, advertisement response, status of goods in transport, weather forecasts, traffic conditions, vehicle maintenance, public transport, downloads and usage of applications, and much more. Big Data and Analytics software and applications …
- 土地試験装置の世界市場2019-2023About this market The increasing number of government initiatives for promoting soil testing will foster the soil testing equipment market growth in the forthcoming years. Soil testing equipment often plays a significant role in determining soil health and requirement for nutrients as maintaining soil health while enhancing agricultural yield. Some government agencies are also focusing on encourag …
- ダーマル顔面フィラー(皮膚充填剤)の世界市場2015-2019About Dermal Facial Fillers Dermal facial fillers are smooth injectable gels made from either synthetic or naturally derived materials like hyaluronic acid. These are used as an effective treatment for correcting folds, deep lines and wrinkles on the face. As skin ages, it begins to lose the collagen filled with hyaluronic acid that helps shape, support and add volume to the face. Dermal fillers p …
- 自動車用ハロゲンヘッドライトの世界市場2019-2023About this market Halogen bulbs are the most economical option for the headlights in automotive vehicles. They are not only cost-effective but are also long-lasting enough to justify their pricing. Halogen reflectors are the most basic type of headlights which are standardly adopted by mini vehicles across the world. In addition, to significantly lower the cost of production of halogen headlights, …
- ブラジル/ロシア/インド/中国の女性不妊手術・処置動向(~2020)BRIC Female Sterilization Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Female Sterilization Procedures Outlook to 2020", provides key market data on the BRIC Female Sterilization Procedures. The report provides procedure volumes within market segments - Mechanical Sterilization Procedures (Tubal Clips and Rings) and Transcervical Sterilization Procedures using Micro-Inserts. T …
- 世界のスマートフォン市場動向(2014-2018)TechNavio’s analysts forecast the Global Smartphones market will grow at a CAGR of 15.3 percent over the period 2013-2018. One of the key factors contributing to this market growth is the declining ASP of smartphones. The Global Smartphones market has also been witnessing increasing demand for large-screen smartphones. However, the high production cost could pose a challenge to the growth of this …